Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation
Understanding what manufacturing changes trigger FDA re-evaluation for generic drugs is key to ensuring drug safety and availability. Major changes like facility transfers, new suppliers, or process upgrades require full review - but new programs are speeding up approvals for U.S.-made generics.
